Fri, 27 Mar 2020 09:09:59 GMT
Mylan, Pfizer postpone merger deal
Drugmaker Mylan's merger deal with Upjohn, Pfizer's off-patent branded drug division, is set to close only in this year's second half, both companies reported, blaming the coronavirus outbreak for the delay.